• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Severe Acute Respiratory Infection (SARI) sentinel surveillance in the country of Georgia, 2015-2017

tetano

Editor, Senior Moderator
PLoS One. 2018 Jul 30;13(7):e0201497. doi: 10.1371/journal.pone.0201497. eCollection 2018.
[h=1]Severe Acute Respiratory Infection (SARI) sentinel surveillance in the country of Georgia, 2015-2017.[/h] Chakhunashvili G[SUP]1[/SUP], Wagner AL[SUP]2[/SUP], Power LE[SUP]2,[/SUP][SUP]3[/SUP], Janusz CB[SUP]2[/SUP], Machablishvili A[SUP]1[/SUP], Karseladze I[SUP]1[/SUP], Tarkhan-Mouravi O[SUP]1[/SUP], Zakhashvili K[SUP]1[/SUP], Imnadze P[SUP]1[/SUP], Gray GC[SUP]4,[/SUP][SUP]5,[/SUP][SUP]6[/SUP], Anderson B[SUP]5[/SUP], Boulton ML[SUP]2,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Severe Acute Respiratory Infection (SARI) causes substantial mortality and morbidity worldwide. The country of Georgia conducts sentinel surveillance to monitor SARI activity and changes in its infectious etiology. This study characterizes the epidemiology of SARI in Georgia over the 2015/16 and 2016/17 influenza seasons, compares clinical presentations by etiology, and estimates influenza vaccine effectiveness using a test-negative design.
[h=4]METHODS:[/h] SARI cases were selected through alternate day systematic sampling between September 2015 and March 2017 at five sentinel surveillance inpatient sites. Nasopharyngeal swabs were tested for respiratory viruses and Mycoplasma pneumoniae using a multiplex diagnostic system. We present SARI case frequencies by demographic characteristics, co-morbidities, and clinical presentation, and used logistic regression to estimate influenza A vaccine effectiveness.
[h=4]RESULTS:[/h] 1,624 patients with SARI were identified. More cases occurred in February (28.7%; 466/1624) than other months. Influenza was the dominant pathogen in December-February, respiratory syncytial virus in March-May, and rhinovirus in June-November. Serious clinical symptoms including breathing difficulties, ICU hospitalization, and artificial ventilation were common among influenza A and human metapneumovirus cases. For influenza A/H3, a protective association between vaccination and disease status was observed when cases with unknown vaccination status were combined with those who were unvaccinated (OR: 0.53, 95% CI: 0.30, 0.97).
[h=4]CONCLUSIONS:[/h] Multi-pathogen diagnostic testing through Georgia's sentinel surveillance provides useful information on etiology, seasonality, and demographic associations. Influenza A and B were associated with more severe outcomes, although the majority of the population studied was unvaccinated. Findings from sentinel surveillance can assist in prevention planning.


PMID: 30059540 DOI: 10.1371/journal.pone.0201497
 
Back
Top Bottom